These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35605837)

  • 1. Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism.
    Zhao J; Wang S; Hee Kim S; Han S; Rico-Bautista E; Sturchler E; Nguyen J; Tan H; Staley C; Karin Kusnetzow A; Betz SF; Johns M; Goulet L; Luo R; Fowler M; Athanacio J; Markison S; Scott Struthers R; Zhu Y
    Bioorg Med Chem Lett; 2022 Sep; 71():128807. PubMed ID: 35605837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists.
    Zhao J; Wang S; Han S; Kim SH; Kusnetzow AK; Nguyen J; Rico-Bautista E; Tan H; Betz SF; Scott Struthers R; Zhu Y
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127391. PubMed ID: 32738999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism.
    Juliana CA; Chai J; Arroyo P; Rico-Bautista E; Betz SF; De León DD
    J Biol Chem; 2023 Jun; 299(6):104816. PubMed ID: 37178920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats.
    Martínez V; Coy DH; Lloyd KC; Taché Y
    Eur J Pharmacol; 1996 Jan; 296(2):153-60. PubMed ID: 8838451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
    Park S; Kamegai J; Kineman RD
    Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-pyridylthioureas: novel nonpeptide somatostatin agonists with SST4 selectivity.
    Liu S; Crider AM; Tang C; Ho B; Ankersen M; Stidsen CE
    Curr Pharm Des; 1999 Apr; 5(4):255-63. PubMed ID: 10101224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
    Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
    Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
    Spary EJ; Maqbool A; Batten TF
    J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
    Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
    Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of somatostatin and angiopeptin on cell proliferation.
    Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP
    Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):500-9. PubMed ID: 10598789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5.
    Helboe L; Møller M; Nørregaard L; Schiødt M; Stidsen CE
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):82-8. PubMed ID: 9387866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
    Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M
    Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
    Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.
    Zhao J; Wang S; Markison S; Kim SH; Han S; Chen M; Kusnetzow AK; Rico-Bautista E; Johns M; Luo R; Struthers RS; Madan A; Zhu Y; Betz SF
    ACS Med Chem Lett; 2023 Jan; 14(1):66-74. PubMed ID: 36655128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.